Adverse drug events (ADEs) cause an estimated 100,000 emergency hospitalizations for seniors each year, yet two thirds involve just a handful of anticoagulants and diabetes medications. A study by researchers from the US CDC, singles out 4 drugs and drug classes: warfarin, oral antiplatelet medications, insulins, and oral hypoglycemic agents. …
Read More »Kids Cereals = Eating Twinkies for Breakfast
According to a new study which reviewed 84 brands of children’s breakfast cereals, two thirds of them contain more added sugar by weight than is recommended by the US government. The Environmental Working Group analysis found that only 1 in 4 children’s cereals meet all of the group’s recommendations, which …
Read More »More than 9 Million U.S. Adults Lost Health Coverage
An estimated 9.3 million American adults lost health insurance coverage as a result of increased unemployment during the recession of 2007-09. The newly published study found that roughly nine times as many Americans lost health insurance coverage in the recession of 2007-09 as in the previous recession of 2001. It …
Read More »Medicare Pays for Intensive Obesity Counseling
Medicare Pays for Intensive Obesity Counseling See this week’s Item #1, Medicare Now Pays for Intensive Obesity Counseling.
Read More »Metformin May Reduce Risk of Cancer
Metformin may reduce the risk of diabetes-associated cancers, including breast cancer. Michigan State University pediatrics professor James Trosko and colleagues from South Korea’s Seoul National University focused on the concept that cancers originate from adult human stem cells and that there are many natural and man-made chemicals that enhance the …
Read More »Omega-3 Fatty Acids Staves Off CV Events in High-risk Patients with Diabetes
Low-dose supplementation with omega-3 fatty acids may protect patients with diabetes and a history of myocardial infarction from ventricular arrhythmia-related events, new data from the Alpha Omega Trial suggest. 1,014 patients aged 60 to 80 years with diabetes were randomly assigned to consume one of four margarines supplemented with daily …
Read More »Sitagliptin/Pioglitazone Combo Application Withdrawn in EU
Sitagliptin/Pioglitazone Combo Application Withdrawn in EU Merck Sharp & Dohme Inc. has withdrawn its marketing authorization application for sitagliptin/pioglitazone (Janacti).
Read More »More Physicians Embrace Web-Based Health Solutions
Datamonitor, the London-based market research firm, estimates the market for telehealth services in the U.S. and Europe will grow from $3 billion in 2009 to nearly $8 billion by 2012. A 2010 survey by Intel also found that 89% of health care decision makers believe telehealth will transform health care …
Read More »Diabetes Can Increase Risk of Bladder Cancer Recurring
A new study has claimed that having diabetes could heighten the chances of the recurrence of bladder cancer, as well as promoting its progression. The research argued that diabetes could be an independent predictor of non-muscle invasive bladder cancer (NMIBC) recurring or progressing. The study which involved 251 patients found …
Read More »Four Drugs Responsible for 100,000 Emergency Hospitalizations for Seniors from Adverse Drug Events Yearly
Two thirds involve just a handful of anticoagulants and diabetes medications according to a study. The study, by researchers from the CDC, singles out 4 drugs and drug classes: warfarin, oral antiplatelet medications, insulins, and oral hypoglycemic agents. Alone or together, they account for 67% of emergency ADE hospitalizations of …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.